ChaMP-CMD: A Phenotype-Blinded, Randomized Controlled, Cross-Over Trial. (2024)
Attributed to:
Characterising disease mechanisms and tailoring therapies for coronary microvascular dysfunction
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1161/circulationaha.123.066680
PubMed Identifier: 37905403
Publication URI: http://europepmc.org/abstract/MED/37905403
Type: Journal Article/Review
Volume: 149
Parent Publication: Circulation
Issue: 1
ISSN: 0009-7322